Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paul M. Barr

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax Treated CLL in Routine Clinical Practice

Clinical Cancer Research
Cancer ResearchOncology
2019English

Long-Term Follow-Up of the RESONATE™ Phase 3 Trial of Ibrutinib Versus Ofatumumab

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Cellular Cytotoxicity of Next Generation CD20 Monoclonal Antibodies

Cancer immunology research
Cancer ResearchImmunology
2018English

Comparative Analysis of Targeted Novel Therapies in Relapsed, Refractory Chronic Lymphocytic Leukaemia

Haematologica
Hematology
2020English

Significant Weight Gain in CLL Patients Treated With Ibrutinib: A Potentially Deleterious Consequence of Therapy

American Journal of Hematology
Hematology
2019English

Tumour Debulking and Reduction in Predicted Risk of Tumour Lysis Syndrome With Single-Agent Ibrutinib in Patients With Chronic Lymphocytic Leukaemia

British Journal of Haematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy